Key facts
- This page summarizes William A. Sullivan's Form 3 filing for Zivo Bioscience, Inc. (ZIVO).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 29 Dec 2025, 17:06.
William A. Sullivan - 19 Dec 2025 Form 3 Insider Report for Zivo Bioscience, Inc. (ZIVO)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ZIVO
- Reported as of
- 19 Dec 2025
- Net transaction value
- $0
- Reporting owner signature
- /s/ William A. Sullivan
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
William A. Sullivan filed Form 3 for Zivo Bioscience, Inc. (ZIVO) on 29 Dec 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001531562
Primary reporting owner
Sullivan William A.
- Relationship
- Chief Financial Officer
- Address
- 2125 BUTTERFIELD ROAD, SUITE 100, TROY
- Signature
- /s/ William A. Sullivan
- Signature date
- 29 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZIVO
holding
No securities are beneficially owned.
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 19 Dec 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.